Next-Generation 3D Scaffolds for Nano-Based Chemotherapeutics Delivery and Cancer Treatment
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shahriar, S. M. Shatil | - |
dc.contributor.author | Andrabi, Syed Muntazir | - |
dc.contributor.author | Islam, Farhana | - |
dc.contributor.author | An, Jeong Man | - |
dc.contributor.author | Schindler, Samantha J. | - |
dc.contributor.author | Matis, Mitchell P. | - |
dc.contributor.author | Lee, Dong Yun | - |
dc.contributor.author | Lee, Yong-Kyu | - |
dc.date.accessioned | 2023-01-25T09:18:15Z | - |
dc.date.available | 2023-01-25T09:18:15Z | - |
dc.date.created | 2023-01-05 | - |
dc.date.issued | 2022-12 | - |
dc.identifier.issn | 1999-4923 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/182177 | - |
dc.description.abstract | Cancer is the leading cause of death after cardiovascular disease. Despite significant advances in cancer research over the past few decades, it is almost impossible to cure end-stage cancer patients and bring them to remission. Adverse effects of chemotherapy are mainly caused by the accumulation of chemotherapeutic agents in normal tissues, and drug resistance hinders the potential therapeutic effects and curing of this disease. New drug formulations need to be developed to overcome these problems and increase the therapeutic index of chemotherapeutics. As a chemotherapeutic delivery platform, three-dimensional (3D) scaffolds are an up-and-coming option because they can respond to biological factors, modify their properties accordingly, and promote site-specific chemotherapeutic deliveries in a sustainable and controlled release manner. This review paper focuses on the features and applications of the variety of 3D scaffold-based nano-delivery systems that could be used to improve local cancer therapy by selectively delivering chemotherapeutics to the target sites in future. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.title | Next-Generation 3D Scaffolds for Nano-Based Chemotherapeutics Delivery and Cancer Treatment | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Dong Yun | - |
dc.identifier.doi | 10.3390/pharmaceutics14122712 | - |
dc.identifier.scopusid | 2-s2.0-85144831143 | - |
dc.identifier.wosid | 000904558500001 | - |
dc.identifier.bibliographicCitation | Pharmaceutics, v.14, no.12, pp.1 - 30 | - |
dc.relation.isPartOf | Pharmaceutics | - |
dc.citation.title | Pharmaceutics | - |
dc.citation.volume | 14 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 30 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | DRUG-DELIVERY | - |
dc.subject.keywordPlus | THERMOSENSITIVE HYDROGEL | - |
dc.subject.keywordPlus | GOLD NANOPARTICLES | - |
dc.subject.keywordPlus | CHITOSAN | - |
dc.subject.keywordPlus | TUMOR | - |
dc.subject.keywordPlus | DOXORUBICIN | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | ACID | - |
dc.subject.keywordPlus | BIOMATERIALS | - |
dc.subject.keywordPlus | PACLITAXEL | - |
dc.subject.keywordAuthor | 3D scaffolds | - |
dc.subject.keywordAuthor | cancer treatment | - |
dc.subject.keywordAuthor | chemotherapeutics | - |
dc.subject.keywordAuthor | drug delivery | - |
dc.subject.keywordAuthor | materials | - |
dc.subject.keywordAuthor | polymers | - |
dc.identifier.url | https://www.mdpi.com/1999-4923/14/12/2712 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.